Overview
Histamine H1 antagonist with pronounced sedative properties. It is used in allergies and as an antitussive, antiemetic, and hypnotic. Doxylamine has also been administered in veterinary applications and was formerly used in parkinsonism.
Indication
用于枯草热、过敏性鼻炎，短期用于失眠。
Associated Conditions
- Common Cold
- Insomnia
- Mild Allergic Rhinitis
- Nausea
- Symptoms Flu
- Vomiting
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/01/14 | Not Applicable | Not yet recruiting | Nawaz Sharif Medical College | ||
2024/04/02 | Phase 1 | Completed | |||
2024/02/14 | Not Applicable | Completed | |||
2022/08/12 | Not Applicable | Completed | |||
2019/04/05 | Phase 1 | Withdrawn | |||
2008/11/24 | Phase 1 | Completed | Procter and Gamble | ||
2008/02/13 | Phase 3 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| BI-MART | 37835-525 | ORAL | 12.5 mg in 30 mL | 5/1/2025 | |
| NUVICARE LLC | 84324-019 | ORAL | 6.25 mg in 1 1 | 5/20/2025 | |
| Publix Super Markets Inc | 56062-763 | ORAL | 12.5 mg in 30 mL | 5/19/2025 | |
| Mylan Pharmaceuticals Inc. | 0378-4615 | ORAL | 10 mg in 1 1 | 1/3/2019 | |
| CVS Pharmacy | 69842-899 | ORAL | 6.25 mg in 1 1 | 6/18/2025 | |
| Lil' Drug Store Products, Inc. | 66715-6805 | ORAL | 6.25 mg in 1 1 | 6/17/2025 | |
| Bryant Ranch Prepack | 72162-1485 | ORAL | 10 mg in 1 1 | 10/14/2020 | |
| Bionpharma Inc., | 69452-206 | ORAL | 10 mg in 1 1 | 12/11/2023 | |
| Topco Associates LLC | 76162-603 | ORAL | 25 mg in 1 1 | 3/26/2025 | |
| Actavis Pharma, Inc. | 0591-2132 | ORAL | 10 mg in 1 1 | 10/24/2023 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| DICLECTIN DELAYED RELEASE TABLETS 10MG/10MG | SIN15301P | TABLET, DELAYED RELEASE | 10mg | 7/20/2017 | |
| BONJESTA EXTENDED-RELEASE TABLETS 20 MG/20 MG | SIN16865P | TABLET, FILM COATED, EXTENDED RELEASE | 20.0mg | 9/18/2023 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Help Us Improve
Your feedback helps us provide better drug information and insights.